OTC stock swing trader
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Only 40k shares left for sell below 0.08. Go break out 0.08 today.
This stock trading like no revenue company.
I sold out at 9 with one tick profits,but missed big profit.
thanks
I missed a chance
news leaked?
Tomorrow huge buyers will come in to buy RDGL, PPS will break out 0.10 any day before Friday. Every one got Christmas gift
Next Monday will be interesting after people readed news. More buyers will come in to buy RDGL shares, PPS will rock
RDGL has bright future, IDE will be approved for sure, not yes or no, just when, soon or sooner, see break out 0.10 next week.at least.
Only things is that people are scared by 5b A/S, a lot of company with 5B shares trading much higher than this company without revenue. This undervalued stock will fly soon and become a winner in 2024.
BCNN is a very undervalued stock, and is a #1 oever sold stock, it should trade at pennies at least now. MMs should correct their mistake.
If IDE approved, the PPS will gap up to $1, not surprised
Stupid sellars sold at low yesterday, now they must buy high. This stock will gap up big any time soon
IDE submit will be very very soon:
With the Breakthrough Device classification, Vivos Inc. is set to expedite its Investigational Device Exemption (IDE) submission to the FDA, paving the way for human clinical trials. This collaboration with the Mayo Clinic for its initial indication marks a significant step forward in the fight against challenging cancer types, offering hope and potentially more effective treatment options to patients globally.
Excellent comments:
RDGL News
New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel
20h
0.00%
11:58 AM EST, December 21, 2023 (Benzinga Newswire)
In a significant advancement for cancer therapy, the Food and Drug Administration (FDA) has awarded RadioGel Precision Radionuclide Therapy the coveted Breakthrough Device Designation. Developed by Vivos Inc. (OTCQB:RDGL), this designation marks a crucial milestone in the treatment of solid metastatic tumors, particularly in lymph nodes associated with papillary thyroid cancer.
How RadioGel Works
RadioGel, a pioneering Yttrium-90-based injectable brachytherapy device, represents a groundbreaking approach to cancer treatment. It is designed for patients who are either not eligible for surgery or have chosen not to undergo the procedure, particularly those with non-radioiodine avid disease and limited burden regional nodal disease.
The therapy involves directly injecting a hydrogel containing yttrium-90 phosphate microparticles into the tumor. This method allows for a more localized and potent radiation treatment compared to traditional external-beam radiation therapies.
Dr. Mike Korenko, CEO of Vivos Inc., expressed his satisfaction with the FDA's decision, citing the thorough review process and the positive results from their Risk Management Report and animal therapy data. "The FDA did a very thorough review. The analysis in our Risk Management Report concluded that RadioGel is intrinsically safe and our animal therapy data verified its effectiveness," Korenko said.
Also Read: Biden's Million Dollar Moonshot - $240 Million Is A Boon For Cancer Research, Will it be a Boost For Pharma Stocks Too?
What's The FDA's Breakthrough Devices Program
The Breakthrough Devices Program by the FDA is designed to accelerate the development and review of innovative technologies that show potential for more effective treatment options. The program's support is instrumental in hastening patient access to promising medical advancements.
RadioGel's hydrogel technology allows for the safe delivery of higher doses necessary for treating non-resectable and radiation-resistant cancers. The product also boasts a short half-life, delivering over 90% of its therapeutic radiation within 10 days.
This feature compares favorably to other treatments that require up to six weeks for a full course of radiation therapy. Additionally, the outpatient nature of the RadioGel therapy means patients can return home without concerns about radiation exposure to family members.
With the Breakthrough Device classification, Vivos Inc. is set to expedite its Investigational Device Exemption (IDE) submission to the FDA, paving the way for human clinical trials. This collaboration with the Mayo Clinic for its initial indication marks a significant step forward in the fight against challenging cancer types, offering hope and potentially more effective treatment options to patients globally.
Now Read: Cannabis Commonly Used As Sleep Aid By Cancer Survivors, New Research Finds
Photo by National Cancer Institute on Unsplash
Write to Benzinga at editorial@benzinga.com
Looks like big rebound by Tomorrow.
Over pull back is over. this stock should go up to green today.
I love your $8 target for buy out.
Little pull back, then go up continue, let's break out 0.10 today
Tomorrow PDPG will move up lets see.
ETEK is R/m winner in 2024,hold on your shares
Tomorrow BCNN will move up and break out 0.002 at least. See big bottom rebound with strong revenue support.
I predict that we will reach 0.20 by end of this year or next Friday, because few supply and huge demond, most shares hold by strong long holders who will not sell below one dollar.
This very undervalued stock looks like it will break out 0.10 Tomorrow if not today. More news will be following to push the PPS run until Big gap up with IDE FDA approval
BB, check out RDGL, first news out, begin to run, more news will coming. Target PPS will be $$. Welcome you to bring your followers to invest in RDGL now, Thank me latter.
Don't worry, sellars will be crying all the time, this stock will make long holders rich, not small profits. Long holders will be winner. WE may see break out 0.10 before Friday.
Let's break out 0.10 by Friday first. RDGL bull market coming, Long holders hold on to become rich, not for small profits like flipper did.
Let's break out 0.10 by Friday first. RDGL bull market coming, Long holders hold on to become rich, not for small profits like flipper did.
RDGL is warming up, and ready to fly, target $1 PPS coming sooner than people think
A very very undervalued stock.in OTC markets, easy to go pennies.
i BELIEVE THAT tOMORROW WE WLL MOVE UP FROM THE BOTTOM lETS GO UP TO 0.0065 AREA THIS TIME.
TODAY'S TWO SELLARS SOLD 500K SHARES AT 0.05 WILL BE CRYING SOON
I believe that this stock will be going up begin today.
A/S was increasing to 5b on OTC yesterday, market over reaction to it. PPS cut down 36% in one day. This stock up and down all big, but trend is going to pennies in this year, so sell high and buy low is a good strige
RDGL PPS big explode coming any time soon!!!!!!!
sold some at 0.003 yesterday, bought back in today at 0.0018. thanks for today's sellar. See pennies soon this year.
Friday sold at 0.0005 only 3 people with 3m shares total, one person bought at 0.00057 with 15m shares. 0.0006 is a good support. So Tomorrow I will see rebound from 0.0006
ETEK stay at 0.0004 for long time, ready to move up from here. R/M news could out soon.
Next week will run continue, not pull back
only one m left now